T49N (p.Thr49Asn) variant of GCK (Hexokinase-4)

T49N (p.Thr49Asn) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.77 / 1. The record also includes published literature and structural context.

T49N (p.Thr49Asn) variant details